On March 5, 2026, Premier Li Qiang delivered the Government Work Report to the Fourth Session of the 14th National People’s Congress (part of the ‘Two Sessions’), reviewing 2025 and outlining the ...

The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular outcomes in persons with type 2 diabetes and chronic kidney disease (CKD).

Ohio Holdings Corp. (NASDAQ: PKOH) today announced its results for the fourth quarter and full year 2025.

This paper examines whether Chinese development finance is associated with faster progress toward Millennium Development Goal style targets in low- and middle-income countries. We combine AidData’s ...

Kinaxis Inc. ( KXS:CA) Q4 2025 Earnings Call March 5, 2026 8:30 AM EST Good morning, and welcome to the Kinaxis Inc. Fiscal 2025 Fourth Quarter and Year-end Results Conference Call. [Operator ...